US Broker Ratings

Exelixis, Inc. (EXEL) Stock Analysis: A Promising Player in Biotechnology with Strong Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL) has emerged as a notable contender in the biotechnology sector, specializing in the development of innovative treatments for challenging cancer types. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Exploring Growth Potential Amidst a 6.95% Upside

For investors with a keen eye on the healthcare sector, Dr. Reddy’s Laboratories Ltd (NYSE: RDY), an Indian pharmaceutical giant, presents a compelling case. With a market capitalization of $11.02..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 31% Upside Potential and Robust Growth Metrics

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a prominent player in the biotechnology industry, situated within the expansive healthcare sector. With a market capitalization of $66.62 billion, this U.S.-based company continues..

Humana Inc. (HUM) Stock Analysis: Navigating a 23.50% Revenue Surge Amidst Valuation Challenges

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, specifically within healthcare plans, currently holds a market capitalization of $42.03 billion. The Louisville, Kentucky-based company is a major..

Tenet Healthcare Corporation (THC): A 50.91% Potential Upside Awaits Investors

Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector with a promising outlook that could pique the interest of investors seeking substantial returns. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 19.97% Upside and Strong Buy Ratings in Focus

The Cooper Companies, Inc. (NYSE: COO), a noteworthy player in the healthcare sector, offers intriguing investment potential with its dual focus on contact lenses and women’s healthcare. With a market..

Neurocrine Biosciences (NBIX) Stock Analysis: A 17.7% Potential Upside Beckons Investors

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, focuses on the discovery and commercialization of pharmaceuticals targeting neurological, psychiatric, endocrine, and immunological disorders. With a market cap..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 38% Potential Upside Amid Strong Market Position

ResMed Inc. (NYSE: RMD) stands as a formidable player in the healthcare sector, specializing in the development and distribution of medical devices and cloud-based software applications aimed at managing respiratory..

DaVita Inc. (DVA) Stock Analysis: Is This Healthcare Giant Poised for Growth?

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector specializing in medical care facilities, primarily provides dialysis services for patients with chronic kidney failure. With a robust market..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 28% Upside in the Healthcare Sector?

For investors eyeing opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents a compelling case. As a leading player in the medical devices industry, Philips is headquartered in..

The Cigna Group (CI) Stock Analysis: Strong Buy Ratings and Potential Upside of 17.62%

The Cigna Group (NYSE: CI) is making waves in the healthcare sector, with a robust market capitalization of $76.58 billion. As a stalwart in the healthcare plans industry, Cigna’s strategic..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 26% Upside Potential Amid Robust Revenue Growth

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a stalwart in the healthcare sector, particularly in diagnostics and research, is capturing the attention of investors with its promising growth trajectory. Headquartered in Westbrook,..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 32.54% Potential Upside for Investors

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, is catching the eyes of investors with its promising potential upside of 32.54%, according to the latest analyst ratings. With..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating Growth Potential Amidst a 20% Upside Forecast

Fresenius Medical Care AG (NYSE: FMS), a global leader in providing dialysis services and products, stands as a key player in the healthcare sector, particularly within the niche of renal..

AstraZeneca PLC (AZN) Stock Analysis: Robust Revenue Growth and a 20.73% Upside Potential

AstraZeneca PLC (AZN) presents a compelling case for investors seeking opportunities within the healthcare sector. With its headquarters in Cambridge, United Kingdom, this biopharmaceutical titan boasts a market capitalization of..

Alcon Inc. (ALC) Stock Analysis: Healthcare Giant with 32.5% Upside Potential

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor interest with a sizeable market capitalization of $32.58..

Centene Corporation (CNC) Stock Analysis: A Healthcare Giant’s Strategic Position Amidst Market Challenges

Centene Corporation (NYSE: CNC), a prominent player in the healthcare plans industry, is navigating a complex market landscape with a market capitalization of $30.78 billion. The St. Louis-based company, founded..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with 59% Potential Upside

Investors in the healthcare sector may want to take a closer look at Insulet Corporation (NASDAQ: PODD), a company renowned for its innovative insulin delivery systems. With a market capitalization..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Potential Amid Strong Revenue Performance

For individual investors keen on the biotechnology sector, Incyte Corporation (NASDAQ: INCY) presents a compelling case with its promising revenue growth and robust product pipeline. With a market capitalization of..

Eli Lilly (LLY) Stock Analysis: A Healthcare Giant with 7.4% Potential Upside and Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture investor attention with its impressive market performance and promising growth prospects. As a leading player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds